Ventyx Biosciences (VTYX) Revenue & Revenue Breakdown
Ventyx Biosciences Revenue Highlights
Ventyx Biosciences Revenue by Period
Ventyx Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Ventyx Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.08M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Ventyx Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
UTHR | United Therapeutics | $2.33B | $714.90M |
ASND | Ascendis Pharma | $266.72M | $95.89M |
IMCR | Immunocore | $249.43M | $75.40M |
TVTX | Travere Therapeutics | $145.24M | $54.12M |
ACLX | Arcellx | $110.32M | $27.38M |
PTGX | Protagonist Therapeutics | $60.00M | $4.17M |
IDYA | IDEAYA Biosciences | $23.39M | - |
GPCR | Structure Therapeutics | - | - |
PCVX | Vaxcyte | - | - |
NUVL | Nuvalent | - | - |
DICE | DICE Therapeutics | - | - |
VRNA | Verona Pharma | - | - |
CERE | Cerevel Therapeutics | - | - |
REPL | Replimune Group | - | - |
SNDX | Syndax Pharmaceuticals | - | $3.50M |
VTYX | Ventyx Biosciences | - | - |
VTYX Revenue FAQ
What is Ventyx Biosciences’s yearly revenue?
Ventyx Biosciences's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. VTYX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Ventyx Biosciences’s quarterly revenue?
Ventyx Biosciences's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). VTYX's quarterly revenue for Q4 2023 was $1.08M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Ventyx Biosciences’s revenue growth rate?
Ventyx Biosciences's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.